Home / Inspections / 1100853

FDA Inspection 1100853 — Teva Parenteral Medicines, Inc.

Teva Parenteral Medicines, Inc. — FEI 2027158

The FDA completed an inspection of Teva Parenteral Medicines, Inc. on August 30, 2019 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 30, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)

Facility

Other inspections at this facility

  • 1149378 (OAI Fri Aug 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 997582 (NAI Mon Dec 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 980903 (VAI Fri Jul 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 882240 (NAI Fri Jun 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 834806 (VAI Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources